MagCath Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
MagCath General Information
Description
Developer of a non-surgical medical device designed to solve a range of female urinary continence problems. The company's device is a single-use soft silicone tube that is inserted in the urethra, where it stays all day and has an inner valve that restores control over all bladder voiding, enabling women to get access to an alternative to mesh surgery.
Contact Information
Website
www.obtinu.dkCorporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
Corporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
MagCath Timeline
MagCath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 12-Nov-2026 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 29-Apr-2025 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 01-Jun-2022 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC | 14-May-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 10-Oct-2017 | $128K | $806K | Completed | Clinical Trials - General | |
| 1. Seed Round | 27-Nov-2016 | $678K | $678K | Completed | Clinical Trials - General |
MagCath Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | 7,768 | $15.34 | $15.34 | 1x | $15.34 | 2.57% | ||
| Ordinary | 47,125 | $14.74 | $14.74 | 1x | $14.74 | 15.58% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MagCath Patents
MagCath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3148487-A1 | A urine flow control system and a magnetic actuator device | Active | 28-May-2014 | ||
| EP-3148487-B1 | A urine flow control system and a magnetic actuator device | Active | 28-May-2014 | ||
| US-20170105826-A1 | A urine flow control system and a magnetic actuator device | Active | 28-May-2014 | ||
| WO-2015180730-A1 | A urine flow control system and a magnetic actuator device | Inactive | 28-May-2014 | ||
| US-10390921-B2 | Urine flow control system and a magnetic actuator device | Active | 28-May-2014 | A61F5/451 |
MagCath Signals
MagCath Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eir Women's Health Accelerator | Accelerator/Incubator | |||
| InnoFounder | Accelerator/Incubator | Minority | ||
| Herax Life Science | Corporation | Minority |
MagCath FAQs
-
When was MagCath founded?
MagCath was founded in 2013.
-
Where is MagCath headquartered?
MagCath is headquartered in Copenhagen, Denmark.
-
What is the size of MagCath?
MagCath has 5 total employees.
-
What industry is MagCath in?
MagCath’s primary industry is Therapeutic Devices.
-
Is MagCath a private or public company?
MagCath is a Private company.
-
What is MagCath’s current revenue?
The current revenue for MagCath is .
-
How much funding has MagCath raised over time?
MagCath has raised $2.61M.
-
Who are MagCath’s investors?
Eir Women's Health Accelerator, InnoFounder, and Herax Life Science have invested in MagCath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process